Literature DB >> 2524972

Atrial natriuretic factor in normal and hypertensive pregnancy.

A L Bond1, P August, M L Druzin, S A Atlas, J E Sealey, J H Laragh.   

Abstract

Atrial natriuretic factor may play a role in the regulation of blood pressure, renal function, and volume homeostasis in normal and pathologic states. Atrial natriuretic factor and plasma renin activity were measured by radioimmunoassay in pregnant women with normal blood pressure (n = 29), chronic hypertension (n = 17), and preeclampsia (n = 18) during the first, second, and third trimesters and in the postpartum period. Serial data were obtained in 11 patients. Nonpregnant age-matched women were used as controls (n = 14). In normal gestation and in chronic hypertension, atrial natriuretic factor levels were in the same range as that in the control group. Mean atrial natriuretic factor was significantly higher in the antepartum and postpartum periods in severe preeclampsia. There was an inverse relationship between atrial natriuretic factor and plasma renin activity in pregnancies complicated by chronic hypertension or preeclampsia. Although fluctuations in atrial natriuretic factor levels did not predict preeclampsia, atrial natriuretic factor did correlate with the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524972     DOI: 10.1016/0002-9378(89)90171-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

Review 1.  Novel Electrocardiographic Patterns for the Prediction of Hypertensive Disorders of Pregnancy--From Pathophysiology to Practical Implications.

Authors:  Fabio Angeli; Enrica Angeli; Paolo Verdecchia
Journal:  Int J Mol Sci       Date:  2015-08-07       Impact factor: 5.923

2.  Clonidine versus captopril for treatment of postpartum very high blood pressure: study protocol for a randomized controlled trial (CLONCAP).

Authors:  Carlos Noronha-Neto; Leila Katz; Isabela C Coutinho; Sabina B Maia; Alex Sandro Rolland Souza; Melania Maria Ramos Amorim
Journal:  Reprod Health       Date:  2013-07-30       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.